AKT1 and non-small cell lung carcinoma: We previously demonstrated that solamargine inhibited the growth of NSCLC cells through inactivation of phosphatidylinositol 3‐kinase/Akt (PI3‐K/Akt) signalling pathway, followed by reduction of transcription factors, such as SP1 and p65, expressions.